Ignite Creation Date:
2025-12-25 @ 3:01 AM
Ignite Modification Date:
2025-12-27 @ 11:04 PM
Study NCT ID:
NCT03718533
Status:
TERMINATED
Last Update Posted:
2024-02-29
First Post:
2018-10-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Efficacy and Safety of Eltrombopag in Patients With Poor Graft Function
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-12-17
Start Date Type:
ACTUAL
Primary Completion Date:
2020-11-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-11-03
Completion Date Type:
ACTUAL
First Submit Date:
2018-10-23
First Submit QC Date:
None
Study First Post Date:
2018-10-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-11-03
Results First Submit QC Date:
None
Results First Post Date:
2024-02-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-27
Last Update Post Date:
2024-02-29
Last Update Post Date Type:
ACTUAL